CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology, Inc. (NYSE American: MAIA) today announced its second broad provisional patent application covering the composition of matter for a new telomere-targeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results